A 6-Week, Randomized, Multicenter, Double-Blind, Parallel, Flexed- and Fixed-dose Study of MG01CI (Metadoxine Extended-Release) 700 Mg and 1400 Mg Compared with Placebo in Adults and Adolescents with Fragile X Syndrome

Awarded By

Contributors

Start/End

  • December 1, 2014 - September 1, 2015